IPSEN PHARMA BIOTECH S.A.S.
IPSEN PHARMA BIOTECH S.A.S.
Industry:
Biotechnology Pharmaceutical
Founded:
1987-01-01
Address:
Signes, Provence-Alpes-Cote D'Azur, France
Country:
France
Status:
Active
Contact:
33 4 94 10 76 76
More informations about "Ipsen Pharma Biotech S.A.S."
Ipsen - Wikipedia
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employee…See details»
Member profile: Ipsen Biopharm Ltd | BIA - bioindustry.org
About Ipsen Biopharm Ltd Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three …See details»
Ipsen Pharma Biotech S.A.S. - Crunchbase Company Profile
Biotechnology Manufacturing Pharmaceutical Headquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Sub-Organization of Ipsen Founded Date 1987 …See details»
Ipsen Pharma Biotech SAS - Company Profile and News
Company profile page for Ipsen Pharma Biotech SAS including stock price, company news, executives, board members, and contact informationSee details»
Ipsen | Fierce Pharma
Ipsen is a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and neuroscience. At Ipsen, we’re dedicated to improving people’s lives and …See details»
Ipsen Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 Ipsen has 5 employees across 49 locations and €3.4 b in annual revenue in FY 2024. See insights on Ipsen including office locations, competitors, revenue, financials, …See details»
Ipsen: Shareholders Board Members Managers and Company …
Ipsen: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information.See details»
About Ipsen | Pioneering Biopharmaceutical Company
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients …See details»
Ipsen Biopharmaceuticals - MassBio
Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.4 billion in 2015. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial …See details»
Ipsen - LinkedIn
Ipsen | 266,364 followers on LinkedIn. We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare …See details»
Ipsen - LinkedIn
Ipsen | 270,274 followers on LinkedIn. We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare …See details»
Ipsen - Crunchbase Company Profile & Funding
Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. Ipsen develops and commercializes innovative medicines in three key therapeutic areas: …See details»
Ipsen: a dynamic, fast-growing specialty care powerhouse
Ipsen: a dynamic, fast-growing specialty care powerhouse Building on its innovative pipeline of oncology, rare disease and neuroscience therapeutics, Ipsen is a global biopharma company …See details»
Ipsen announces changes to its Executive Committee
2 days ago Ipsen also depends on third parties to develop and market some of its medicines which could potentially generate substantial royalties; these partners could behave in such …See details»
Ipsen: who we are
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and societySee details»
Ipsen announces changes to its Executive Committee
2 days ago Ipsen must face or might face competition from generic medicine that might translate into a loss of market share. Furthermore, the research and development process involves …See details»
Ipsen announces changes to its Executive Committee - The Spec
2 days ago PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care biopharmaceutical company, today announced the following changes to its …See details»
Ipsen SA: Shareholders Board Members Managers and Company …
Jul 14, 2025 Ipsen SA: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Xetra: I7G | XetraSee details»
À propos d’Ipsen | Groupe biopharmaceutique pionnier
Focalisés sur les médicaments transformateurs en oncologie, dans les maladies rares et en neurosciences, nous avons pour ambition d’être un groupe biopharmaceutique de taille …See details»
Exelixis’ Partner Ipsen Receives European Commission Approval for ...
1 day ago In 2016, Exelixis granted Ipsen Pharma SAS exclusive rights for the commercialization and further clinical development of cabozantinib outside of the U.S. and Japan.See details»